Coronavirus vaccines developed by Pfizer and Moderna appeared to remain effective against a subtype of the Indian virus variant, according to early findings presented Tuesday from researchers at Emory University. However, the majority of blood samples from prior infection and all samples from vaccinated individuals appeared to remain effective at blocking the variant. The study found that 79% of samples from previously infected individuals, and all blood samples from vaccinated individuals, blocked the Indian virus variant. In other words, about 20% of samples from previously infected individuals lost their ability to block the Indian variant. However, there isn’t enough data yet to indicate whether the Indian variant poses a heightened risk of more severe illness or death, he noted.

Source: Fox News May 11, 2021 21:33 UTC